These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17078470)

  • 1. Pathological fracture as a manifestation of extramedullary blastic crisis in chronic myelogenous leukemia: report of one case.
    Yu HH; Lu MY; Lin DT; Lin KH; Tang JL; Jou ST
    Acta Paediatr Taiwan; 2006; 47(3):150-4. PubMed ID: 17078470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of chronic myelogenous leukemia responding to imatinib mesilate (Glivec) after relapse of blastic crisis following allogeneic bone marrow transplantation].
    Fujisawa S; Yano K; Kobayashi M
    Gan To Kagaku Ryoho; 2003 Mar; 30(3):427-30. PubMed ID: 12669406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term remission with imatinib mesylate in Philadelphia chromosome-positive AML presenting as primary extramedullary myeloid sarcoma.
    Ahmed MS; Kroft SH; Davis NB; King DM; Cheng YC
    Leuk Res; 2008 Sep; 32(9):1476-9. PubMed ID: 18308388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imatinib mesylate-sensitive blast crisis immediately after discontinuation of imatinib mesylate therapy in chronic myelogenous leukemia: report of two cases.
    Higashi T; Tsukada J; Kato C; Iwashige A; Mizobe T; Machida S; Morimoto H; Ogawa R; Toda Y; Tanaka Y
    Am J Hematol; 2004 Jul; 76(3):275-8. PubMed ID: 15224366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promyelocytic blast crisis of chronic myeloid leukemia during imatinib treatment.
    Chung HJ; Chi HS; Cho YU; Park CJ; Seo EJ; Kim KH; Lee JH
    Ann Clin Lab Sci; 2008; 38(3):283-6. PubMed ID: 18715859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CNS blast crisis of chronic myelogenous leukemia in a patient with a major cytogenetic response in bone marrow associated with low levels of imatinib mesylate and its N-desmethylated metabolite in cerebral spinal fluid.
    Bornhauser M; Jenke A; Freiberg-Richter J; Radke J; Schuler US; Mohr B; Ehninger G; Schleyer E
    Ann Hematol; 2004 Jun; 83(6):401-2. PubMed ID: 14673623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extramedullary disease in Ph'-positive chronic myelogenous leukemia: frequency, clinical features and prognostic significance.
    Inverardi D; Lazzarino M; Morra E; Bernasconi P; Merante S; Canevari A; Pagnucco G; Bernasconi C
    Haematologica; 1990; 75(2):146-8. PubMed ID: 2358205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gelatinous transformation of bone marrow in chronic myeloid leukemia during treatment with imatinib mesylate: a disease or a drug effect?
    Ram R; Gafter-Gvili A; Okon E; Pazgal I; Shpilberg O; Raanani P
    Acta Haematol; 2008; 119(2):104-7. PubMed ID: 18367829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiac tamponade in the blastic crisis of chronic myelogenous leukemia.
    Yamauchi K; Arimori S; Nagao T
    Tokai J Exp Clin Med; 1992 Jul; 17(2):89-93. PubMed ID: 1440659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell regulation and the development of blast crisis in chronic myeloid leukemia: Implications for the outcome of Imatinib treatment and discontinuation.
    Wodarz D
    Med Hypotheses; 2008; 70(1):128-36. PubMed ID: 17566666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imatinib-associated neutropenia may not be overcome by filgrastim treatment in patients with blastic phase of chronic myeloid leukaemia.
    Zaucha JM; Wyrowinska E; Prejzner W; Calbecka M; Hellmann A
    Clin Lab Haematol; 2006 Jun; 28(3):208-10. PubMed ID: 16706939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow aplasia--a rare complication of imatinib therapy in CML patients.
    Srinivas U; Pillai LS; Kumar R; Pati HP; Saxena R
    Am J Hematol; 2007 Apr; 82(4):314-6. PubMed ID: 17013815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biphenotypic extramedullary blast crisis as a presenting manifestation of Philadelphia chromosome-positive CML in a child.
    Ganessan K; Goel R; Kumar K; Bakhshi S
    Pediatr Hematol Oncol; 2007; 24(3):195-8. PubMed ID: 17454789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extramedullary blast crisis in chronic myeloid leukemia].
    Cervantes F; Rozman M; Nicolás JM; López Guillermo A; Rozman C
    Sangre (Barc); 1989 Apr; 34(2):96-8. PubMed ID: 2756456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of ABL kinase domain mutations to imatinib resistance in different subsets of Philadelphia-positive patients: by the GIMEMA Working Party on Chronic Myeloid Leukemia.
    Soverini S; Colarossi S; Gnani A; Rosti G; Castagnetti F; Poerio A; Iacobucci I; Amabile M; Abruzzese E; Orlandi E; Radaelli F; Ciccone F; Tiribelli M; di Lorenzo R; Caracciolo C; Izzo B; Pane F; Saglio G; Baccarani M; Martinelli G;
    Clin Cancer Res; 2006 Dec; 12(24):7374-9. PubMed ID: 17189410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic myeloid leukemia blast crisis arises from progenitors.
    Michor F
    Stem Cells; 2007 May; 25(5):1114-8. PubMed ID: 17218393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extramedullary blast crisis occurring in a Philadelphia-positive chronic myeloid leukemia patient with major cytogenetic response to imatinib.
    Breccia M; Nanni M; Mancini F; Russo E; Mecarocci S; Alimena G
    Haematologica; 2004 Apr; 89(4):ECR11. PubMed ID: 15075103
    [No Abstract]   [Full Text] [Related]  

  • 18. [Extramedullary blastic crisis of chronic myelogenous leukemia--a case with various additional chromosomal appearance].
    Nakao Y; Ohta T; Koh K; Hashimoto S; Takekawa K; Hirai N; Tanaka K; Hasuike T; Hirai M; Ohta K
    Rinsho Byori; 1994 Apr; 42(4):425-9. PubMed ID: 8176852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isolated CNS lymphoid blast crisis in a patient with imatinib-resistant chronic myelogenous leukemia: case report and review of the literature.
    Aftimos P; Nasr F
    Leuk Res; 2009 Nov; 33(11):e178-80. PubMed ID: 19446330
    [No Abstract]   [Full Text] [Related]  

  • 20. Case of chronic-phase chronic myelogenous leukemia with an abdominal hematopoietic tumor of leukemic clone origin.
    Sakakura M; Ohishi K; Nomura K; Katayama N; Nishii K; Masuya M; Nakase K; Shiku H
    Am J Hematol; 2004 Oct; 77(2):167-70. PubMed ID: 15389905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.